Triple-negative breast cancer (TNBC) is a specific subtype of breast cancer that lacks the estrogen receptor (ER) (Depianto et al. 2010), progesterone receptor (PR) (Dey et al. 2013), and the human epidermal growth factor receptor 2 (HER-2). Here, PGR is linked to triple-negative breast carcinoma.